Clinical Trial Detail

NCT ID NCT01642251
Title Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

small cell carcinoma

lung non-small cell carcinoma

lung small cell carcinoma


Cisplatin + Etoposide


Age Groups: adult

No variant requirements are available.